Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinations

Abstract

10.3324/haematol.2018.201483Haematologica10461209-122

    Similar works

    Full text

    thumbnail-image

    Available Versions